1. |
Zhou ZR, Wang CC, Yang ZZ, et al. Phyllodes tumors of the breast: diagnosis, treatment and prognostic factors related to recurrence. J Thorac Dis, 2016, 8(11): 3361-3368.
|
2. |
WHO Classification of Tumours of the Breast. Fourth ed. WHO-OMS, 2018 May 16 [Internet]. cited http://apps.who.int/bookorders/anglais/detart1.jspcodlan=1&codcol=70&codcch=4004.
|
3. |
Chopra S, Muralikrishnan V, Brotto M. Youngest case of ductal carcinoma in situ arising within a benign phyllodes tumour: A case report. Int J Surg Case Rep, 2016, 24: 67-69.
|
4. |
Agha RA, Fowler AJ, Saetta A, et al. A protocol for the development of reporting criteria for surgical case reports: The SCARE statement. Int J Surg, 2016, 27: 187-189.
|
5. |
Ossa CA, Herazo F, Gil M, et al. Phyllodes tumor of the breast: a clinic-pathologic study of 77 cases in a Hispanic cohort. Colomb Med (Cali), 2015, 46(3): 104-108.
|
6. |
Mituś J, Reinfuss M, Mituś JW, et al. Malignant phyllodes tumor of the breast: treatment and prognosis. Breast J, 2014, 20(6): 639-644.
|
7. |
Islam S, Shah J, Harnarayan P, et al. The largest and neglected giant phyllodes tumor of the breast—A case report and literature review. Int J Surg Case Rep, 2016, 26: 96-100.
|
8. |
Xiao M, Zhu Q, Jiang Y, et al. Local recurrent phyllodes tumors of the breast: clinical and sonographic features. J Ultrasound Med, 2015, 34(9): 1631-1638.
|
9. |
Kim S, Kim JY, Kim DH, et al. Analysis of phyllodes tumor recurrence according to the histologic grade. Breast Cancer Res Treat, 2013, 141(3): 353-363.
|
10. |
Fischer KM, S J Brooks J, Ugras SK. Invasive lobular carcinoma involving a borderline phyllodes tumor. Breast J, 2018, 24(6): 1076-1077.
|
11. |
张珊珊, 秦云, 张轶华, 等. 复发性乳腺叶状肿瘤的临床病理特征分析. 中国实用医药, 2017, 12(8): 90-91.
|
12. |
Adesoye T, Neuman HB, Wilke LG, et al. Current trends in the management of phyllodes tumors of the breast. Ann Surg Oncol, 2016, 23(10): 3199-3205.
|
13. |
Velázquez-Dohorn M, Gamboa-Domínguez A, Medina-Franco H. Phyllodes tumor of the breast: clinicopathologic analysis of 22 cases. Rev Invest Clin, 2013, 65(3): 214-220.
|
14. |
Farias-Eisner GT, Small K, Swistel A, et al. Immediate implant breast reconstruction with acellular dermal matrix for treatment of a large recurrent malignant phyllodes tumor. Aesthetic Plast Surg, 2014, 38(2): 373-378.
|
15. |
Yoshida M, Sekine S, Ogawa R, et al. Frequent MED12 mutations in phyllodes tumours of the breast. Br J Cancer, 2015, 112(10): 1703-1708.
|
16. |
谢菲, 王殊. 乳腺叶状肿瘤的诊断及手术治疗. 中国实用外科杂志, 2016, 36(7): 741-743.
|
17. |
Onkendi EO, Jimenez RE, Spears GM, et al. Surgical treatment of borderline and malignant phyllodes tumors: the effect of the extent of resection and tumor characteristics on patient outcome. Ann Surg Oncol, 2014, 21(10): 3304-3309.
|
18. |
Barth RJ Jr. Histologic features predict local recurrence after breast conserving therapy of phyllodes tumors. Breast Cancer Res Treat, 1999, 57(3): 291-295.
|
19. |
Chao X, Chen K, Zeng J, et al. Adjuvant radiotherapy and chemotherapy for patients with breast phyllodes tumors: a systematic review and meta-analysis. BMC Cancer, 2019, 19(1): 372.
|
20. |
National Comprehensive Cancer Network. Phyllodes Tumor. Version 1. 2016. Accessed January 25, 2016. http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf.
|
21. |
Haldosén LA, Zhao C, Dahlman-Wright K. Estrogen receptor beta in breast cancer. Mol Cell Endocrinol, 2014, 382(1): 665-672.
|
22. |
Madhu Krishna B, Chaudhary S, Mishra DR, et al. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer. BMC Cancer, 2018, 18(1): 607.
|
23. |
Kakugawa Y, Tada H, Kawai M, et al. Associations of obesity and physical activity with serum and intratumoral sex steroid hormone levels among postmenopausal women with breast cancer: analysis of paired serum and tumor tissue samples. Breast Cancer Res Treat, 2017, 162(1): 115-125.
|